This year we’ve returned to our Top 100 format for The Power List, showcasing the tremendous range of talent, ingenuity and leadership present across all corners of analytical science on a global scale.

Cookies

Like most websites The Analytical Scientist uses cookies. In order to deliver a
personalized, responsive service and to improve the site, we remember and store information about how you use
it.
Learn more.

Tracking Designer Drugs

The Problem

The rapid increase of novel and variant synthetic cannabinoids designed to circumvent regulation has resulted in many unknown analytes and metabolites that must be detected in forensic and toxicological urine samples. How can we more capably detect trace amounts of these drugs in complex matrices, such as urine and blood?

Read the full article now

Log in or register to read this article in full and gain access to
The Analytical Scientist’s entire content archive. It’s FREE and always will be!

Or Login via Social Media

About the Author

Dave Strong

Dave Strong graduated with a PhD in analytical chemistry from the University of Bristol, UK, in 2012 and currently performs toxicological testing on human samples at HFL Sports Science. “My work entails extensive research and method development in both biological and man-made matrices, which includes substantial wet chemistry, such as solid phase extraction”. Dave has developed numerous methods from scratch, such as the extraction of caffeine from saliva, the extraction of octopamine from human urine…